nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Feeling abnormal—Dactinomycin—muscle cancer	0.00191	0.00191	CcSEcCtD
Goserelin—Ill-defined disorder—Etoposide—muscle cancer	0.00191	0.00191	CcSEcCtD
Goserelin—Anaemia—Etoposide—muscle cancer	0.0019	0.0019	CcSEcCtD
Goserelin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0019	0.0019	CcSEcCtD
Goserelin—Hot flush—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00189	0.00189	CcSEcCtD
Goserelin—Increased appetite—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Goserelin—Menopausal symptoms—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Goserelin—Insomnia—Vincristine—muscle cancer	0.00187	0.00187	CcSEcCtD
Goserelin—Renal impairment—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Goserelin—Paraesthesia—Vincristine—muscle cancer	0.00186	0.00186	CcSEcCtD
Goserelin—Malaise—Etoposide—muscle cancer	0.00185	0.00185	CcSEcCtD
Goserelin—Breast disorder—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Goserelin—Leukopenia—Etoposide—muscle cancer	0.00184	0.00184	CcSEcCtD
Goserelin—Abdominal pain—Dactinomycin—muscle cancer	0.00183	0.00183	CcSEcCtD
Goserelin—Body temperature increased—Dactinomycin—muscle cancer	0.00183	0.00183	CcSEcCtD
Goserelin—Cardiac failure—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Goserelin—Lethargy—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Goserelin—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Goserelin—Decreased appetite—Vincristine—muscle cancer	0.0018	0.0018	CcSEcCtD
Goserelin—Cough—Etoposide—muscle cancer	0.00179	0.00179	CcSEcCtD
Goserelin—Fatigue—Vincristine—muscle cancer	0.00179	0.00179	CcSEcCtD
Goserelin—Convulsion—Etoposide—muscle cancer	0.00178	0.00178	CcSEcCtD
Goserelin—Hypertension—Etoposide—muscle cancer	0.00178	0.00178	CcSEcCtD
Goserelin—Pain—Vincristine—muscle cancer	0.00177	0.00177	CcSEcCtD
Goserelin—Constipation—Vincristine—muscle cancer	0.00177	0.00177	CcSEcCtD
Goserelin—Osteoarthritis—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Goserelin—Chest pain—Etoposide—muscle cancer	0.00175	0.00175	CcSEcCtD
Goserelin—Migraine—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Goserelin—Affect lability—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Goserelin—Discomfort—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Goserelin—Hypersensitivity—Dactinomycin—muscle cancer	0.00171	0.00171	CcSEcCtD
Goserelin—Gastrointestinal pain—Vincristine—muscle cancer	0.00169	0.00169	CcSEcCtD
Goserelin—Confusional state—Etoposide—muscle cancer	0.00169	0.00169	CcSEcCtD
Goserelin—Anaphylactic shock—Etoposide—muscle cancer	0.00168	0.00168	CcSEcCtD
Goserelin—Mood swings—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Goserelin—Infection—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Goserelin—Asthenia—Dactinomycin—muscle cancer	0.00166	0.00166	CcSEcCtD
Goserelin—Dysuria—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Goserelin—Thrombocytopenia—Etoposide—muscle cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Tachycardia—Etoposide—muscle cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Body temperature increased—Vincristine—muscle cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Abdominal pain—Vincristine—muscle cancer	0.00164	0.00164	CcSEcCtD
Goserelin—Skin disorder—Etoposide—muscle cancer	0.00163	0.00163	CcSEcCtD
Goserelin—Erectile dysfunction—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Goserelin—Dry skin—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Goserelin—Hyperhidrosis—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Goserelin—Photosensitivity reaction—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Goserelin—Breast disorder—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Goserelin—Anorexia—Etoposide—muscle cancer	0.0016	0.0016	CcSEcCtD
Goserelin—Diarrhoea—Dactinomycin—muscle cancer	0.00159	0.00159	CcSEcCtD
Goserelin—Pneumonia—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Goserelin—Drowsiness—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Goserelin—Depression—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Goserelin—Hypotension—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Goserelin—Renal failure—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Goserelin—Influenza—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—muscle cancer	0.00153	0.00153	CcSEcCtD
Goserelin—Sweating—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Goserelin—Paraesthesia—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Goserelin—Haematuria—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Goserelin—Dyspnoea—Etoposide—muscle cancer	0.0015	0.0015	CcSEcCtD
Goserelin—Somnolence—Etoposide—muscle cancer	0.00149	0.00149	CcSEcCtD
Goserelin—Angina pectoris—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Goserelin—Asthenia—Vincristine—muscle cancer	0.00149	0.00149	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—muscle cancer	0.00147	0.00147	CcSEcCtD
Goserelin—Bronchitis—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Goserelin—Rash—Dactinomycin—muscle cancer	0.00146	0.00146	CcSEcCtD
Goserelin—Decreased appetite—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Goserelin—Fatigue—Etoposide—muscle cancer	0.00145	0.00145	CcSEcCtD
Goserelin—Pain—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Goserelin—Constipation—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Goserelin—Dysuria—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Goserelin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Goserelin—Haemoglobin—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Goserelin—Diarrhoea—Vincristine—muscle cancer	0.00142	0.00142	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Goserelin—Pollakiuria—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Goserelin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Goserelin—Weight increased—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Goserelin—Feeling abnormal—Etoposide—muscle cancer	0.00138	0.00138	CcSEcCtD
Goserelin—Hyperglycaemia—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Goserelin—Nausea—Dactinomycin—muscle cancer	0.00138	0.00138	CcSEcCtD
Goserelin—Pneumonia—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Goserelin—Gastrointestinal pain—Etoposide—muscle cancer	0.00137	0.00137	CcSEcCtD
Goserelin—Dizziness—Vincristine—muscle cancer	0.00137	0.00137	CcSEcCtD
Goserelin—Drowsiness—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Goserelin—Renal failure—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Goserelin—Urticaria—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Jaundice—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Abdominal pain—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Body temperature increased—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Urinary tract infection—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Vomiting—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Goserelin—Sweating—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Goserelin—Rash—Vincristine—muscle cancer	0.00131	0.00131	CcSEcCtD
Goserelin—Dermatitis—Vincristine—muscle cancer	0.00131	0.00131	CcSEcCtD
Goserelin—Haematuria—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Goserelin—Headache—Vincristine—muscle cancer	0.0013	0.0013	CcSEcCtD
Goserelin—Epistaxis—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Sinusitis—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Goserelin—Chills—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Goserelin—Alopecia—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Goserelin—Hypersensitivity—Etoposide—muscle cancer	0.00124	0.00124	CcSEcCtD
Goserelin—Erythema—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Nausea—Vincristine—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Goserelin—Pharyngitis—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Goserelin—Asthenia—Etoposide—muscle cancer	0.0012	0.0012	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Goserelin—Back pain—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Goserelin—Pruritus—Etoposide—muscle cancer	0.00119	0.00119	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Goserelin—Diarrhoea—Etoposide—muscle cancer	0.00115	0.00115	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Anaemia—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Cardiac disorder—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Malaise—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Dizziness—Etoposide—muscle cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Chills—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Goserelin—Arrhythmia—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Goserelin—Cough—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Goserelin—Mental disorder—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Convulsion—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Vomiting—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Erythema—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Malnutrition—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Goserelin—Rash—Etoposide—muscle cancer	0.00106	0.00106	CcSEcCtD
Goserelin—Dermatitis—Etoposide—muscle cancer	0.00106	0.00106	CcSEcCtD
Goserelin—Headache—Etoposide—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Flatulence—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Chest pain—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Myalgia—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Tension—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Goserelin—Discomfort—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Goserelin—Back pain—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Goserelin—Muscle spasms—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Goserelin—Confusional state—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Vision blurred—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Goserelin—Infection—Methotrexate—muscle cancer	0.000999	0.000999	CcSEcCtD
Goserelin—Nausea—Etoposide—muscle cancer	0.000997	0.000997	CcSEcCtD
Goserelin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00099	0.00099	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—muscle cancer	0.000986	0.000986	CcSEcCtD
Goserelin—Anaemia—Doxorubicin—muscle cancer	0.000986	0.000986	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—muscle cancer	0.000984	0.000984	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—muscle cancer	0.000977	0.000977	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—muscle cancer	0.000972	0.000972	CcSEcCtD
Goserelin—Malaise—Doxorubicin—muscle cancer	0.000962	0.000962	CcSEcCtD
Goserelin—Anorexia—Methotrexate—muscle cancer	0.000958	0.000958	CcSEcCtD
Goserelin—Leukopenia—Doxorubicin—muscle cancer	0.000955	0.000955	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—muscle cancer	0.000943	0.000943	CcSEcCtD
Goserelin—Hypotension—Methotrexate—muscle cancer	0.00094	0.00094	CcSEcCtD
Goserelin—Cough—Doxorubicin—muscle cancer	0.000931	0.000931	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—muscle cancer	0.000924	0.000924	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—muscle cancer	0.000921	0.000921	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000916	0.000916	CcSEcCtD
Goserelin—Insomnia—Methotrexate—muscle cancer	0.000909	0.000909	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—muscle cancer	0.000908	0.000908	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—muscle cancer	0.000908	0.000908	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—muscle cancer	0.000908	0.000908	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—muscle cancer	0.000905	0.000905	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—muscle cancer	0.000903	0.000903	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000902	0.000902	CcSEcCtD
Goserelin—Discomfort—Doxorubicin—muscle cancer	0.000897	0.000897	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—muscle cancer	0.000896	0.000896	CcSEcCtD
Goserelin—Somnolence—Methotrexate—muscle cancer	0.000894	0.000894	CcSEcCtD
Goserelin—Dry mouth—Doxorubicin—muscle cancer	0.000888	0.000888	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—muscle cancer	0.000885	0.000885	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—muscle cancer	0.000878	0.000878	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—muscle cancer	0.000874	0.000874	CcSEcCtD
Goserelin—Oedema—Doxorubicin—muscle cancer	0.000871	0.000871	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000871	0.000871	CcSEcCtD
Goserelin—Fatigue—Methotrexate—muscle cancer	0.000867	0.000867	CcSEcCtD
Goserelin—Infection—Doxorubicin—muscle cancer	0.000865	0.000865	CcSEcCtD
Goserelin—Pain—Methotrexate—muscle cancer	0.00086	0.00086	CcSEcCtD
Goserelin—Shock—Doxorubicin—muscle cancer	0.000857	0.000857	CcSEcCtD
Goserelin—Nervous system disorder—Doxorubicin—muscle cancer	0.000854	0.000854	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000852	0.000852	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—muscle cancer	0.00085	0.00085	CcSEcCtD
Goserelin—Skin disorder—Doxorubicin—muscle cancer	0.000846	0.000846	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000842	0.000842	CcSEcCtD
Goserelin—Anorexia—Doxorubicin—muscle cancer	0.00083	0.00083	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—muscle cancer	0.000829	0.000829	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000822	0.000822	CcSEcCtD
Goserelin—Hypotension—Doxorubicin—muscle cancer	0.000814	0.000814	CcSEcCtD
Goserelin—Urticaria—Methotrexate—muscle cancer	0.000799	0.000799	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—muscle cancer	0.000795	0.000795	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—muscle cancer	0.000795	0.000795	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—muscle cancer	0.000787	0.000787	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Goserelin—Dyspnoea—Doxorubicin—muscle cancer	0.000776	0.000776	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—muscle cancer	0.000774	0.000774	CcSEcCtD
Goserelin—Dyspepsia—Doxorubicin—muscle cancer	0.000766	0.000766	CcSEcCtD
Goserelin—Decreased appetite—Doxorubicin—muscle cancer	0.000757	0.000757	CcSEcCtD
Goserelin—Fatigue—Doxorubicin—muscle cancer	0.000751	0.000751	CcSEcCtD
Goserelin—Constipation—Doxorubicin—muscle cancer	0.000744	0.000744	CcSEcCtD
Goserelin—Pain—Doxorubicin—muscle cancer	0.000744	0.000744	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—muscle cancer	0.000741	0.000741	CcSEcCtD
Goserelin—Asthenia—Methotrexate—muscle cancer	0.000721	0.000721	CcSEcCtD
Goserelin—Feeling abnormal—Doxorubicin—muscle cancer	0.000717	0.000717	CcSEcCtD
Goserelin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000712	0.000712	CcSEcCtD
Goserelin—Pruritus—Methotrexate—muscle cancer	0.000711	0.000711	CcSEcCtD
Goserelin—Urticaria—Doxorubicin—muscle cancer	0.000692	0.000692	CcSEcCtD
Goserelin—Abdominal pain—Doxorubicin—muscle cancer	0.000688	0.000688	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—muscle cancer	0.000688	0.000688	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—muscle cancer	0.000688	0.000688	CcSEcCtD
Goserelin—Dizziness—Methotrexate—muscle cancer	0.000665	0.000665	CcSEcCtD
Goserelin—Hypersensitivity—Doxorubicin—muscle cancer	0.000641	0.000641	CcSEcCtD
Goserelin—Vomiting—Methotrexate—muscle cancer	0.000639	0.000639	CcSEcCtD
Goserelin—Rash—Methotrexate—muscle cancer	0.000634	0.000634	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—muscle cancer	0.000633	0.000633	CcSEcCtD
Goserelin—Headache—Methotrexate—muscle cancer	0.00063	0.00063	CcSEcCtD
Goserelin—Asthenia—Doxorubicin—muscle cancer	0.000625	0.000625	CcSEcCtD
Goserelin—Pruritus—Doxorubicin—muscle cancer	0.000616	0.000616	CcSEcCtD
Goserelin—Nausea—Methotrexate—muscle cancer	0.000597	0.000597	CcSEcCtD
Goserelin—Diarrhoea—Doxorubicin—muscle cancer	0.000596	0.000596	CcSEcCtD
Goserelin—Dizziness—Doxorubicin—muscle cancer	0.000576	0.000576	CcSEcCtD
Goserelin—Vomiting—Doxorubicin—muscle cancer	0.000554	0.000554	CcSEcCtD
Goserelin—Rash—Doxorubicin—muscle cancer	0.000549	0.000549	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—muscle cancer	0.000548	0.000548	CcSEcCtD
Goserelin—Headache—Doxorubicin—muscle cancer	0.000545	0.000545	CcSEcCtD
Goserelin—Nausea—Doxorubicin—muscle cancer	0.000517	0.000517	CcSEcCtD
